Walleye Capital

Walleye Capital’s Fate Therapeutics FATE Stock Holding History

Walleye Capital’s Portfolio FATE Stock Details FATE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-72,286	Closed	-$57.1K	–	4677
2025 Q1	$57.1K	Sell	72,286 -1,010,806	-93%	-$1.24M	﹤0.01%	3812
2024 Q4	$1.79M	Buy	1,083,092 +1,015,483	+1,502%	+$2.56M	0.02%	1883
2024 Q3	$237K	Buy	67,609 +49,009	+263%	+$191K	﹤0.01%	3874
2024 Q2	$61K	Buy	+18,600	New	+$81.4K	﹤0.01%	4878
2024 Q1	–	Sell	-39,229	Closed	-$147K	–	5580
2023 Q4	$147K	Sell	39,229 -62,756	-62%	-$148K	﹤0.01%	3852
2023 Q3	$216K	Sell	101,985 -286,567	-74%	-$949K	﹤0.01%	3492
2023 Q2	$1.85M	Buy	388,552 +71,245	+22%	+$393K	0.03%	1386
2023 Q1	$1.81M	Buy	317,307 +303,102	+2,134%	+$1.83M	0.04%	785
2022 Q4	$143K	Buy	+14,205	New	+$267K	﹤0.01%	2233
2022 Q3	–	Hold	0	–	–	–	3371
2022 Q2	–	Sell	-27,175	Closed	-$1.05M	–	2486
2022 Q1	$1.05M	Buy	+27,175	New	+$1.05M	0.03%	614
2021 Q4	–	Sell	-4,505	Closed	-$267	–	2168
2021 Q3	$267	Buy	+4,505	New	+$353K	0.01%	1072
2021 Q1	–	Sell	-8,410	Closed	-$765	–	1227
2020 Q4	$765	Buy	+8,410	New	+$522K	0.06%	359

Other funds holding FATE

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return

Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Acadian Asset Management

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return